Aldawsari Mohammed F, Anwer Md Khalid, Ahmed Mohammed Muqtader, Fatima Farhat, Soliman Gamal A, Bhatia Saurabh, Zafar Ameeduzzafar, Aboudzadeh M Ali
Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj 11942, Saudi Arabia.
Department of Pharmacology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, P.O. Box 173, Al-Kharj 11942, Saudi Arabia.
Polymers (Basel). 2021 Oct 13;13(20):3512. doi: 10.3390/polym13203512.
Sildenafil citrate (SLC) is a frequently used medication (Viagra®) for the treatment of erectile dysfunction (ED). Due to its poor solubility, SLC suffers from a delayed onset of action and poor bioavailability. Hence, the aim of the proposed work was to prepare and evaluate solid dispersions (SDs) with hydrophilic polymers (Kolliphor® P188, Kollidon® 30, and Kollidon®-VA64), in order to enhance the dissolution and efficacy of SLC. The SLC-SDs were prepared using a solvent evaporation method (at the ratio drug/polymer, 1:1, /) and characterized by Differential Scanning Calorimetry (DSC), Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), Scanning electron microscope (SEM), drug content, yield, and in vitro release studies. Based on this evaluation, SDs (SLC-KVA64) were optimized, with a maximum release of drug (99.74%) after 2 h for all the developed formulas. The SDs (SLC-KVA64) were further tested for sexual behavior activity in male rats, and significant enhancements in copulatory efficiency (81.6%) and inter-copulatory efficiency (44.9%) were noted in comparison to the pure SLC drug, when exposed to the optimized SLC-KVA64 formulae. Therefore, SD using Kollidon®-VA64 could be regarded as a potential strategy for improving the solubility, in vitro dissolution, and therapeutic efficacy of SLC.
枸橼酸西地那非(SLC)是一种常用于治疗勃起功能障碍(ED)的药物(万艾可®)。由于其溶解度差,SLC起效延迟且生物利用度低。因此,本研究的目的是制备并评估与亲水性聚合物(聚氧乙烯蓖麻油EL® P188、聚维酮® 30和共聚维酮® -VA64)形成的固体分散体(SDs),以提高SLC的溶出度和疗效。采用溶剂蒸发法(药物/聚合物比例为1:1)制备SLC-SDs,并通过差示扫描量热法(DSC)、傅里叶变换红外光谱法(FTIR)、X射线衍射法(XRD)、扫描电子显微镜(SEM)、药物含量、产率和体外释放研究对其进行表征。基于该评估,优化了SDs(SLC-KVA64),所有开发配方在2小时后药物最大释放率为99.74%。对SDs(SLC-KVA64)进行雄性大鼠性行为活性进一步测试,与纯SLC药物相比,当给予优化的SLC-KVA64配方时,交配效率(提高81.6%)和交配间期效率(提高44.9%)有显著提高。因此,使用共聚维酮® -VA64的SD可被视为提高SLC溶解度、体外溶出度和治疗效果的潜在策略。